A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Ozempic is effective in treating a severe form of liver disease that ... 534 participants received 2.4 mg of semaglutide weekly, while 266 had a placebo. Based on liver biopsy reports, 62.9 ...

Demand for weight-loss drugs, including GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, has surged in the United States. In May 2024, a KFF Health Tracking Poll found that approximately 6 ...

The cash-based acquisition – the financial terms of which are not being disclosed – will expand Hims & Hers' presence in the ...

It's plainly apparent that Novo Nordisk has had May 22 circled its calendar since February, when the FDA began the countdown ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

There are 182 clinical trials for Alzheimer’s treatments under way in 2025—an 11% increase on the previous year—testing 138 ...

Cortigent is developing the Stroke Recovery System to improve the recovery of arm and hand movement in people who have suffered paralysis due to stroke Spin-off will allow Vivani to focus on its ...

"Social media will turn everyone into brain-dead zombies with a medieval-level understanding of the real world." ...

Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...

Global Technologies, LTD (OTCPK: GTLL) is a public, multi-operational company committed to building scalable businesses in ...